These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 11173001)

  • 1. Neuromuscular paralysis as a pharmacodynamic probe to assess organ function during liver transplantation.
    Gao L; Ramzan I; Baker B
    J Clin Anesth; 2000 Dec; 12(8):615-20. PubMed ID: 11173001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rocuronium infusion requirements and plasma concentrations at constant levels of neuromuscular paralysis during three phases of liver transplantation.
    Gao L; Ramzan I; Baker B
    J Clin Anesth; 2003 Jun; 15(4):257-66. PubMed ID: 12888160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rocuronium plasma concentrations during three phases of liver transplantation: relationship with early postoperative graft liver function.
    Gao L; Ramzan I; Baker B
    Br J Anaesth; 2002 Jun; 88(6):764-70. PubMed ID: 12173191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Newer neuromuscular blocking agents: how do they compare with established agents?
    Sparr HJ; Beaufort TM; Fuchs-Buder T
    Drugs; 2001; 61(7):919-42. PubMed ID: 11434449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of rocuronium during the three stages of liver transplantation.
    Fisher DM; Ramsay MA; Hein HA; Marcel RJ; Sharma M; Ramsay KJ; Miller RD
    Anesthesiology; 1997 Jun; 86(6):1306-16. PubMed ID: 9197300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the pharmacodynamics of rocuronium and vecuronium during halothane anaesthesia.
    Booth MG; Marsh B; Bryden FM; Robertson EN; Baird WL
    Anaesthesia; 1992 Oct; 47(10):832-4. PubMed ID: 1359803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, dose-response study of sugammadex given for the reversal of deep rocuronium- or vecuronium-induced neuromuscular blockade under sevoflurane anesthesia.
    Duvaldestin P; Kuizenga K; Saldien V; Claudius C; Servin F; Klein J; Debaene B; Heeringa M
    Anesth Analg; 2010 Jan; 110(1):74-82. PubMed ID: 19933538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rocuronium bromide and organ function.
    Bevan DR
    Eur J Anaesthesiol Suppl; 1994; 9():87-91. PubMed ID: 7925215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duration of rocuronium-induced neuromuscular block during liver transplantation: a predictor of primary allograft function.
    Marcel RJ; Ramsay MA; Hein HA; Nguyen AT; Ramsay KJ; Suit CT; Miller RD
    Anesth Analg; 1997 Apr; 84(4):870-4. PubMed ID: 9085973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuromuscular pharmacodynamics of rocuronium in patients with major burns.
    Han T; Kim H; Bae J; Kim K; Martyn JA
    Anesth Analg; 2004 Aug; 99(2):386-92, table of contents. PubMed ID: 15271712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Newer neuromuscular blocking agents.
    Bevan DR
    Pharmacol Toxicol; 1994 Jan; 74(1):3-9. PubMed ID: 8159634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical pharmacokinetics of rocuronium bromide.
    Khuenl-Brady KS; Sparr H
    Clin Pharmacokinet; 1996 Sep; 31(3):174-83. PubMed ID: 8877248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and pharmacodynamics of rocuronium in patients with cirrhosis.
    Khalil M; D'Honneur G; Duvaldestin P; Slavov V; De Hys C; Gomeni R
    Anesthesiology; 1994 Jun; 80(6):1241-7. PubMed ID: 8010470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenobarbital influence on neuromuscular block produced by rocuronium in rats.
    Braga Ade F; Barcelos CC; Braga FS; Fernandes SC; Franco YO; Mantovani M; Simioni LR
    Acta Cir Bras; 2008; 23(4):343-7. PubMed ID: 18641804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Residual paralysis induced by either vecuronium or rocuronium after reversal with pyridostigmine.
    Kim KS; Lew SH; Cho HY; Cheong MA
    Anesth Analg; 2002 Dec; 95(6):1656-60, table of contents. PubMed ID: 12456433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacokinetics of rocuronium bromide in hepatic cirrhosis.
    Hunter JM
    Eur J Anaesthesiol Suppl; 1995 Sep; 11():39-41. PubMed ID: 8557004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions between mivacurium, rocuronium, and vecuronium during general anesthesia.
    Kim DW; Joshi GP; White PF; Johnson ER
    Anesth Analg; 1996 Oct; 83(4):818-22. PubMed ID: 8831328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical pharmacokinetics of the newer neuromuscular blocking drugs.
    Atherton DP; Hunter JM
    Clin Pharmacokinet; 1999 Mar; 36(3):169-89. PubMed ID: 10223167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of the aminosteroidal non-depolarizing neuromuscular blocking agents rocuronium and vecuronium in plasma with liquid chromatography-tandem mass spectroscopy.
    Gutteck-Amsler U; Rentsch KM
    Clin Chem; 2000 Sep; 46(9):1413-4. PubMed ID: 10973876
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative potency of steroidal neuromuscular blocking drugs and isobolographic analysis of the interaction between rocuronium and other aminosteroids.
    Naguib M; Samarkandi AH; Bakhamees HS; Magboul MA; el-Bakry AK
    Br J Anaesth; 1995 Jul; 75(1):37-42. PubMed ID: 7669466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.